Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextralipoate tromethamine injection vs thioctic acid for diabetic peripheral neuropathy
CTR20190026Phase 2Completed
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexlipotam tromethamine in diabetic polyneuropathy (DPN), sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd.. Started Apr 2019; status: completed.
02
Drugs
dexlipotam tromethamine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20190026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190026.